Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-12 Purchase | 2024-09-16 5:30 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 40,000 | $2.5342 | $101,368 | 259,995 (Indirect Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 1,792 | $18.73 | $33,560 | 161,315 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:11 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 2,716 | $16.33 | $44,347 | 123,107 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:54 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $26.94 | $875,451 | 457,158 (Indirect Direct) | View |
| 2023-03-16 Sale(A) | 2023-03-24 6:48 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $31.89 | $1,036,459 | 567,676 (Direct) | View |
| 2023-03-16 Sale | 2023-03-20 8:18 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $31.89 | $1,036,459 | 120,676 (Direct) | View |
| 2023-01-06 Sale | 2023-01-10 7:20 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 2,658 | $36.3 | $96,481 | 34,009 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 4:04 pm | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 1,810 | $55.1 | $99,735 | 2,845 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-23 Exercise(A) | 2024-09-05 7:55 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $0 | 457,158 (Direct) | View |
| 2023-08-23 Exercise(A) | 2024-09-05 7:55 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $6.88 | 457,158 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-11 4:58 pm | N/A 2034-06-09 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:23 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 211,180 | $0 | 372,495 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:44 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 100,000 | $0 | 223,107 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-04 4:07 pm | N/A 2034-01-03 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 4,925 | $0 | 4,925 (Direct) | View |
| 2023-10-31 Gift | 2023-11-02 3:33 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 11,072 | $0 | 125,823 (Indirect) | View |
| 2023-08-23 Exercise | 2023-08-24 4:15 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $0 | 489,658 (Direct) | View |
| 2023-08-23 Exercise | 2023-08-24 4:15 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $6.88 | 489,658 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 8:54 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $0 | 457,158 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 8:54 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $6.88 | 457,158 (Direct) | View |
| 2022-01-06 Conversion(A) | 2023-04-26 7:34 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 19,482 | $0 | 19,482 (Indirect) | View |
Ownership(A) | 2023-04-26 7:30 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 0 | $0 | 19,482 (Indirect) | View |
| 2023-03-16 Option Award(A) | 2023-03-24 6:48 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 119,167 | $0 | 567,676 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:48 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $0 | 567,676 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:48 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $6.88 | 567,676 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 8:18 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 119,167 | $0 | 120,676 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 9:33 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 5,000 | $0 | 483,667 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 9:33 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 5,000 | $6.88 | 483,667 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:36 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-02-11 Option Award | 2022-03-28 4:30 pm | N/A 2032-02-11 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 8:28 pm | N/A 2032-01-06 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 174,167 | $0 | 174,167 (Direct) | View |
Ownership | 2022-01-06 5:21 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 0 | $0 | 452,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 4:11 pm | N/A 2031-06-10 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:18 pm | N/A 2030-06-09 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-14 4:58 pm | N/A N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 21,983 | $11.74 | 247,497 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-14 4:58 pm | N/A 2020-05-17 | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 21,983 | $0 | 247,497 (Direct) | View |
| 2020-03-01 Exercise | 2020-03-03 4:27 pm | 2017-03-01 N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 4,500 | $0 | 225,514 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 4:27 pm | N/A N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 1,323 | $20.84 | 225,514 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-24 4:11 pm | 2021-02-20 2030-02-20 | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 126,811 | $0 | 366,623 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:11 pm | N/A N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 1,712 | $20.24 | 366,623 (Direct) | View |
| 2020-02-21 Exercise | 2020-02-24 4:11 pm | 2020-02-21 N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 5,825 | $0 | 366,623 (Direct) | View |
| 2020-02-16 Tax Withholding | 2020-02-18 4:07 pm | N/A N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 2,076 | $17.77 | 227,974 (Direct) | View |
| 2020-02-16 Exercise | 2020-02-18 4:07 pm | 2019-02-16 N/A | Alkermes plc. | ALKS | FRATES JAMES M SVP, Alks Inc; CFO ALKS | 6,375 | $0 | 227,974 (Direct) | View |
| 2019-08-29 Ownership | 2020-02-04 6:02 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 1,500 | $0 | 1,035 (Direct) | View |